approval
saveSANDIMMUNE (CYCLOSPORINE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 213d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 213d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 213d ago
- approvalCYCLOSPORINE — FDA approvalNov 28, 2025 · 311d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1103d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1103d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1103d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 16, 2022 · 1664d ago
same company · ±60 days · 5
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalJan 15, 2016
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalJan 15, 2016
- approvalKESIMPTA: KESIMPTA (OFATUMUMAB) — FDA approvalJan 19, 2016
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalNov 20, 2015
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalNov 20, 2015
comments(0)
5-min edit window · permanent after that